The following navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move through main tier links and expand / close menus in sub tiers. Up and Down arrows will open main tier menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Join a seminar to learn more from the physicians and health experts at Samaritan Health Services. Watch recordings of past seminars and see a schedule for our next events.
Learn where to get vaccinated near you.
Whether you need walk-in care or have a medical emergency, Samaritan Health Services is here to help with five hospitals and eight clinics offering walk-in care for urgent needs.
As one of the largest employers in Benton, Lincoln and Linn counties. Samaritan Health Services offers many rewarding careers with very competitive wage and benefits packages.
Samaritan Health Services continuously reviews its performance in the areas of quality care and patient safety. Learn about current initiatives and see our ratings.
A treatment that Good Samaritan Regional Medical Center helped pioneer in the fight against COVID‑19 will soon take on a new purpose. In the months to come the treatment will be used in a nationwide study of septic shock, a life‑threatening reaction to infection.
The PURIFY‑RCT study will investigate the use of the Seraph 100 Microbind Affinity Blood Filter as a blood purification treatment for critically ill patients with septic shock. The study is funded by the Department of Defense and sponsored by the Uniformed Services University, Henry M. Jackson Foundation for the Advancement of Military Medicine and ExThera Medical Corp., the filter’s manufacturer.
For more than a year, critical care specialist Brian Delmonaco, MD, and his intensive care team have found success using this blood filter on some of the sickest of the sick COVID‑19 patients. Now the ICU staff will use their expertise in the study that may last up to two years.
“A study like the PURIFY‑RCT permits our critical care team to network with larger research centers,” said Dr. Delmonaco.
The Seraph 100 filter received emergency use authorization from the U.S. Food and Drug Administration in April 2020 to treat critically ill COVID‑19 patients.
Participants involved in the study will be ICU patients who have septic shock, bacteria in their blood and are on certain medications to raise abnormally low blood pressure.
Good Samaritan, the only participant in the Pacific Northwest, has prestigious medical partners in the study that include Baylor Scott & White Health, University of Texas Southwestern Medical Center and University of Southern California.
“Good Samaritan Regional Medical Center is a small but mighty clinical site for the PURIFY‑RCT study. The caliber of the other clinical sites in terms of academic excellence puts us together with very esteemed company,” said Dr. Delmonaco.
The research, which will enroll 60 patients, will compare in a ratio of 2‑to‑1 a larger group receiving Seraph filter treatment for up to four days and a smaller group receiving normal ICU care.
“It is an honor to be a part of the PURIFY‑RCT study and to showcase our hospital among the nation’s best health research institutions,” said Dr. Delmonaco.
Need a doctor? Call 800-863-5241 Hours: Monday through Friday, 8 a.m. to 5 p.m. or inquire online
Billing questions? Call 800-640-5339 Hours: Monday through Friday, 8 a.m. to 5 p.m. or inquire online
Sign up for a free health newsletter.
©2022 Samaritan Health Services. All Rights Reserved. Site MapTerms of Use & Privacy Policy
Website design & development by Americaneagle.com